ArticleBiomolecules2023

The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling.

Sandip Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.